Cart
sales@molnova.com
Ursulcholic acid trisodium salt
CAS No. 89232-83-7
Ursulcholic acid trisodium salt( —— )
Catalog No. M36135 CAS No. 89232-83-7
Ursulcholic acid trisodium salt (Ursodeoxycholic acid disulfate trisodium salt) is a soluble form of ursodeoxycholic acid which has antihyperlipidemia and gallbladder activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 129 | Get Quote |
|
| 5MG | 200 | Get Quote |
|
| 10MG | 295 | Get Quote |
|
| 25MG | 539 | Get Quote |
|
| 50MG | 718 | Get Quote |
|
| 100MG | 981 | Get Quote |
|
| 500MG | 1962 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameUrsulcholic acid trisodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrsulcholic acid trisodium salt (Ursodeoxycholic acid disulfate trisodium salt) is a soluble form of ursodeoxycholic acid which has antihyperlipidemia and gallbladder activity.
-
DescriptionUrsulcholic acid trisodium salt (Ursodeoxycholic acid disulfate trisodium salt) is a soluble form of ursodeoxycholic acid which has antihyperlipidemia and gallbladder activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number89232-83-7
-
Formula Weight618.64
-
Molecular FormulaC24H37Na3O10S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(O[C@@H]1[C@]2([H])[C@@](CC[C@]3([C@@]2([H])CC[C@]3([H])[C@H](C)CCC([O-])=O)C)([H])[C@@]4([C@](C[C@@H](CC4)OS(=O)([O-])=O)([H])C1)C)([O-])=O.[Na+].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Disodium Phosphate
Disodium Phosphate is an inorganic compound used usually as food additives. It is also functions as a corrosion inhibitor.
-
Sodium Tartrate
Sodium Tartrate is a food additive used as an emulsifier and binding agent in food products.
-
PhosTAC7
PhosTAC7 successfully induced ternary protein complex formation and dephosphorylation of phosphatidylserine 318 (pS318) by Halo-FOXO3a in a dose-dependent manner.
